Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06300814
Other study ID # ERU-HEM-EU-01
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 1, 2024
Est. completion date December 1, 2024

Study information

Verified date March 2024
Source TC Erciyes University
Contact Emre Usta
Phone 05377171571
Email usta_emre_1907@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study was planned as a randomized controlled experimental study with a pretest-posttest design to determine the effect of parental supervision and video-guided progressive relaxation exercise (PRE) and music recital on sleep, quality of life and emotional states in children with epilepsy aged 9-16 years. The main questions it aims to answer are as follows: According to the evaluation of children with epilepsy, does the progressive relaxation exercise applied to children have an effect on sleep, quality of life and emotional states? According to the evaluation of children with epilepsy, does music recital applied to children have an effect on sleep quality of life and emotional states? The study consisted of 45 children (15 children in the progressive relaxation exercise group, 15 children in the music recital group and 15 children in the control group). Ethics committee approval, permission from the institutions and informed consent of the children were obtained for the conduct of the study. A value of p<0.05 was considered statistically significant in data analysis.


Description:

This randomized controlled experimental study will be conducted to evaluate the effect of progressive relaxation exercise and music recital before going to sleep on sleep, quality of life and emotional state in children with epilepsy. The study will be conducted with children aged 9-16 years and their mothers hospitalized in a tertiary care hospital. Children in the progressive relaxation exercise (n=15), music recital (n=15) and control (n=15) groups will be selected similarly in terms of age, gender, educational status, duration of diagnosis and number. The data of the study will be collected with the Quality of Life Scale in Children Parent Form (QoLQS-PPP), Pediatric Symptom Checklist-17 (PSCL-17), Child Sleep Habits Questionnaire (CSHQ) to be administered to mothers and the Quality of Life Scale in Children Child and Adolescent Form (QoLQ-C), Me and My Emotions in Children and Adolescents Scale (MEAS), and Sleep Deprivation Scale for Children and Adolescents (PSSAD) to be administered to children. Children in the PRE group will be asked to do PRE before going to sleep five days a week (4 weeks) with a PRE video for a total of 15 minutes each session. Children in the music group will be asked to listen to the selected music before going to sleep five days a week (4 weeks) for a total of 15 minutes each session. These scales will be applied to the children before the interventions (Time 1). After the interventions were performed five days a week (4 weeks) for a total of 15 minutes each session before going to sleep, the same scales will be applied again (Time 2) and the results of the study will be compared. Children in the control group will receive standard treatment. In the evaluation of the data showing normal distribution; Student t (between 2 groups) and One Way ANOVA (more than 2 groups) tests will be used to test whether there is a difference between two independent groups; Paired-samples t test will be used to test whether there is a difference between the measurements before and after the intervention. In the evaluation of non-normally distributed data; Mann-Whitney U (between 2 groups) and Kruskal-Wallis Analysis of Variance (more than 2 groups) tests will be used to test whether there is a difference between two independent groups; Wilcoxon Paired-Samples Test will be used to test whether there is a difference between pre and post intervention measurements. A value of p<0.05 was considered statistically significant in data analysis.


Recruitment information / eligibility

Status Recruiting
Enrollment 45
Est. completion date December 1, 2024
Est. primary completion date March 1, 2024
Accepts healthy volunteers No
Gender All
Age group 9 Years to 16 Years
Eligibility Inclusion Criteria: - Between the ages of 9-16, - Does not have a chronic or genetic disease other than epilepsy, - No mental, visual or hearing impairment, - Having a mother who is at least a primary school graduate, - Both he and his mother are open to communication and cooperation, - Children who both themselves and their mothers volunteer to participate in the research and give verbal and written consent. Exclusion Criteria: - Not between the ages of 9-16, - Having a chronic or genetic disease other than epilepsy, - Mentally, visually or hearing impaired, - Mothers who are not primary school graduates, - Both he and his mother are not open to communication and cooperation, - Neither they nor their mothers volunteered to participate in the research, - Children and mothers without smart phones

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Progressive relaxation exercise group
A video containing the progressive relaxation exercise was sent to the phones of the mothers of children diagnosed with epilepsy in the intervention group to whom progressive relaxation exercise would be applied, and the children applied progressive relaxation exercise (15 minutes of progressive relaxation exercise before bedtime for a total of 4 weeks, 5 days a week).
Music recital group
The link of the music recital (link) was sent to the phones of the mothers of children diagnosed with epilepsy in the intervention group, where the music concert will be applied, and the children listened to it (music concert was applied for 15 minutes before going to bed, 5 days a week for a total of 4 weeks).

Locations

Country Name City State
Turkey Erciyes University Kayseri

Sponsors (1)

Lead Sponsor Collaborator
TC Erciyes University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary The Children's Sleep Habits Questionnaire (CSHQ) CSHQ, which consists of 8 subscales (resistance to going to bed, difficulty sleeping, total sleep time, sleep anxiety, frequent waking up at night, sleepiness during the day, breathing-related sleep problems and parasomnia) and 33 items, is scored 1-3 points (1 = rarely…. 3 = It is generally evaluated as). Average 30 days: pre-intervention measurement (Time 1), 4 weeks intervention, immediately after the intervention measurement (Time 2)
Secondary The Pediatric Quality of Life Inventory (PedsQL) Scale; It consists of 23 items in total: physical health = 8, emotional functionality = 5, social functionality = 5, school functionality = 5 items. The same items are available in all child and parent forms created according to age groups. When answering the scale, a score of 0-4 was determined for each question (0 = never… 4 = almost always). Average 30 days: pre-intervention measurement (Time 1), 4 weeks intervention, immediately after the intervention measurement (Time 2)
Secondary The Me and My School Questionnaire (M&MS) It consists of a total of 16 items: emotional difficulties = 10, behavioral problems = 6 items. Each item in the scale; It evaluates to never = 0, sometimes = 1, always = 2. High scores on each subscale indicate the likelihood of mental health problems Average 30 days: pre-intervention measurement (Time 1), 4 weeks intervention, immediately after the intervention measurement (Time 2)
See also
  Status Clinical Trial Phase
Recruiting NCT06202976 - Mapping Epileptic Networks Using Multimodal Imaging
Recruiting NCT04770337 - Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy N/A
Recruiting NCT05885646 - Effect of Sulthiame on EEG in Childhood Epilepsy Syndromes
Completed NCT04545346 - The Potential of a Low Glutamate Diet as a Treatment for Pediatric Epilepsy N/A
Completed NCT06400966 - The Effect of Jigsaw Technique on Childhood Epileptic Seizure Management Knowledge and Attitudes of Nursing Students N/A
Not yet recruiting NCT06388577 - The Effect of the Training Programme Based on the Health Promotion Model Given to Parents N/A
Not yet recruiting NCT06402526 - Evaluating the Efficacy of a Mobile Epilepsy Education Application N/A
Terminated NCT04639310 - XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy Phase 3
Withdrawn NCT04308252 - Comparison of Microbiome Composition and Biomarkers in Pharmaco Resistant and Pharmaco-Sensitive Epilepsy
Active, not recruiting NCT03916848 - Novel Network Analysis of Intracranial Stereoelectroencephalography N/A
Recruiting NCT05439876 - Getting SMART for Pediatric Epilepsy Phase 2/Phase 3
Recruiting NCT05323682 - Physical Excercise Program in Children With Drug-resistant Epilepsy N/A
Recruiting NCT04584385 - Advanced EEG Technology in Childhood Epilepsy
Not yet recruiting NCT04219930 - Nucleotide Protein -3 in Epileptic Children
Completed NCT04020484 - Making Mindfulness Matter© in Children With Epilepsy N/A
Recruiting NCT06093490 - Detecting Absence Seizures Using Hyperventilation and Eye Movement Recordings
Completed NCT05675254 - The Prevalence and Risk Factors of Coagulopathy in Pediatric Epilepsy Surgery Patients
Recruiting NCT05740423 - Standardization of Anti-Seizure Medications Withdrawals After Seizure Remission in Young Patients With Epilepsy
Terminated NCT04912856 - An Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEE Phase 3
Recruiting NCT06310954 - Ketogenic Diet in Pediatric Intractable Epilepsy N/A